Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20211008052699N2
IRCT20211008052699N2
Recruiting
Phase 3

Investigating the effect of using the blood of a brain dead liver donor patient during liver transplantation on a liver recipient patient at Abu Ali Sina organ transplant center in 2023

Shiraz University of Medical Sciences0 sites124 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIVER TRANSPLANT.Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedureY83.0

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
IVER TRANSPLANT.
Sponsor
Shiraz University of Medical Sciences
Enrollment
124
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Stability in vital signs (heart rate less than 100 R/M, systolic pressure more than 100 mmHg).
  • •Hemoglobin level above 11
  • •Age 18 to 40 years
  • •having blood group and RH between the donor and the recipient
  • •The same immunological conditions between donor and recipient in terms of cytomegaloviruses
  • •Matching based on sender and receiver cross match
  • •Transplantation from a brain dead donor
  • •Whole liver transplant
  • •Stability of vital signs at the time of liver transplant surgery
  • •Failure to receive inotrope before the transplant procedure

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Clinical study to evaluate the efficacy of blood purification therapy on cholesterol crystal embolismcholesterol crystal embolism
JPRN-UMIN000009306Incorporated administrative agency, Japan Community Health care Organization, Sendai Hospital35
Completed
N/A
Clinical study using human blood and PBMCs about IgG4-related disease.
JPRN-UMIN000012977ational Institutes of Biomedical Innovation,Health and Nutrition10
Completed
N/A
A study to evaluate the response of whole blood stimulation with lipopolysaccharide or other inducers and its in vitro inhibition in healthy volunteers, and patients with a chronic inflammatory conditioatheroscleroserheumatoid arthritis100110821000381610003216
NL-OMON38316Centre for Human Drug Research250
Not Yet Recruiting
N/A
Comprehensive study for the potential blood-based biomarkers for NSCLC patients treated with lazertinibNeoplasms
KCT0008254Kyung Hee University Hospital100
Recruiting
N/A
Effect of Blood Transfusion in Covid-19Respiratory status of patients with Covid 19.COVID-19, virus identifiedU07.1
IRCT20201003048904N1Boushehr University of Medical Sciences40